Alexion Pharmaceuticals, Inc.

MetLife Investment Management, LLC ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

5/17/2024

Shares

50,524

Value ($000)

9,282

Weight

0.1%

2018 Q3 - 2021 Q2 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	5/17/2024	9,282	0.1%	50,524	6/30/2021
2021 Q1	5/17/2024	7,902	0.1%	51,677	3/31/2021
2020 Q4	5/24/2024	8,193	0.1%	52,437	12/31/2020
2020 Q3	5/24/2024	6,276	0.1%	54,847	9/30/2020
2020 Q2	5/24/2024	6,428	0.1%	57,269	6/30/2020
2020 Q1	7/12/2023	5,122	0.1%	57,040	3/31/2020
2019 Q4	7/12/2023	6,358	0.1%	58,786	12/31/2019
2019 Q3	7/12/2023	5,976	0.1%	61,020	9/30/2019
2019 Q2	7/12/2023	8,096	0.1%	61,808	6/30/2019
2019 Q1	7/13/2023	8,585	0.1%	63,511	3/31/2019
2018 Q4	7/13/2023	6,210	0.1%	63,789	12/31/2018
2018 Q3	7/13/2023	9,010	0.1%	64,818	9/30/2018